Cystatin C as an antagonist of tgf-b and methods related thereto

Details for Australian Patent Application No. 2004281152 (hide)

Owner National Jewish Health

Inventors Schiemann, William P.

Agent Freehills

Pub. Number AU-B-2004281152

PCT Pub. Number WO2005/037221

Priority 60/511,794 15.10.03 US

Filing date 15 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 19 January 2012

International Classifications

C07K 1/00 (2006.01) General processes for the preparation of peptides

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/037221 Priority application(s): WO2005/037221

19 January 2012 Application Accepted

  Published as AU-B-2004281152

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281153-Treatment of arthritic conditions, chronic inflammation or pain

2004281151-Substituted benzazoles and use thereof as inhibitors of Raf kinase